The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn't enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here's why they did so poorly.
Analogic makes a (bad) dealShares of Analogic dropped 13% after the imaging specialist accepted an offer from private equity company Altaris Capital Partners to buy it out. Stocks usually rise after getting acquisition bids, but the Altaris offer for $1.1 billion priced Analogic at just $84 per share, compared to the $96 per share closing price for the stock on Tuesday. Altaris justified the price by arguing that it represented a 25% premium to where Analogic traded nearly a year ago when it first announced its intention to seek strategic alternatives that could lead to a sale. Nevertheless, investors are highly disappointed that this was the best that Analogic could do, especially after announcing such strong earnings recently and given the generally favorable environment for tech stocks more broadly.
Top 10 Value Stocks To Watch For 2022: Western Asset Bond Fund(WEA)
Western Asset Premier Bond Fund (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income and capital appreciation by investing primarily in a diversified portfolio of investment-grade bonds. The Fund invests substantially all of its assets in bonds, including corporate bonds, the United States Government and Agency securities, and mortgage-related securities.
The Fund's portfolio includes corporate bonds and notes, Yankee bonds, the United States Government securities, asset-backed and mortgage-backed securities, foreign bonds and preferred stocks. Western Asset Premier Bond Fund invests in various industries, including advertising, aerospace/defense, banking and finance, cable, chemicals, diversified financial services, electric, gas and pipeline utilities, investment banking/brokerage, telecommunications, transportation, and oil and gas. The Fund's investment advisors are Western Asset Management Company and Western Asset Management Company Limited, which are wholly owned subsidiaries of Legg Mason, Inc.
Advisors' Opinion:- [By Shane Hupp]
Western Asset Premier Bond Fund (NYSE:WEA) hit a new 52-week high and low during mid-day trading on Thursday following a dividend announcement from the company. The stock traded as low as $12.63 and last traded at $12.63, with a volume of 12970 shares changing hands. The stock had previously closed at $12.63.
Top 10 Value Stocks To Watch For 2022: Apache Corporation(APA)
Apache Corporation, together with its subsidiaries, engages in the exploration, development, and production of natural gas, crude oil, and natural gas liquids. The company has exploration and production interests in the Gulf of Mexico, the Gulf Coast, east Texas, the Permian basin, the Anadarko basin, and the Western Sedimentary basin of Canada; and onshore Egypt, offshore Western Australia, offshore the United Kingdom in the North Sea, and onshore Argentina, as well as on the Chilean side of the island of Tierra del Fuego. Apache Corporation sells its natural gas to local distribution companies, utilities, end-users, integrated oil and gas companies, and marketers; and crude oil to integrated oil companies, marketing and transportation companies, and refiners. As of December 31, 2009, it had total estimated proved reserves of 1,067 million barrels of crude oil, condensate, and natural gas liquids, as well as 7.8 trillion cubic feet of natural gas. The company was founded in 1954 and is based in Houston, Texas.
Advisors' Opinion:- [By Motley Fool Transcribing]
Apache (NYSE:APA) Q4 2018 Earnings Conference CallFeb. 28, 2019 11:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Garrett Baldwin]
To see why we believe some of the richest players in the world are preparing for a market collapse, click here.
Stocks to Watch Today: WTW, CHK, BBY Shares of Weight Watchers International Inc. (NASDAQ: WTW) cratered more than 30% after the company fell well short of earnings expectations after the bell and issued worse-than-expected 2019 guidance. The firm reported adjusted earnings of $0.46, a figure that missed expectations by $0.14. The firm also issued weak forward guidance. After yesterday's slump, Oprah Winfrey's stake in the company plunged by a whopping $48 million. Shares of Chesapeake Energy Corp. (NYSE: CHK) popped 10.2% after the natural gas producer reported earnings before the bell. Higher natural gas prices in the fourth quarter helped bolster the firm's bottom line. Total natural gas sales jumped 37% in Q4 to $3.07 billion, well above analysts' expectations of $2.28 billion. That strong natural gas revenue helped the firm report adjusted EPS of $0.49, which was a 49% jump year over year. Shares of Best Buy Co. Inc. (NYSE: BBY) popped 10% after the electronics retailer topped Wall Street earnings expectations before the bell. The firm's profit of $2.72 topped consensus expectations by $0.15 per share. The firm cited stronger-than-expected same-store sales, hiked its dividend from $0.45 to $0.50, and issued a positive 2019 outlook. Today, look for more earnings reports from Apache Corp. (NYSE: APA), Box Inc. (NYSE: BOX), Campbell Soup Co. (NYSE: CPB), Dean Foods Co. (NYSE: DF), Fitbit Inc. (NYSE: FIT), HP Inc. (NYSE: HPQ), L Brands Inc. (NYSE: LB), Lowe's Co. Inc. (NYSE: LOW), Office Depot Inc. (NYSE: ODP), and Square Inc. (NYSE: SQ).Follow Money Morning on Facebook, Twitter, and LinkedIn.
- [By Joseph Griffin]
Meridian Wealth Management LLC purchased a new stake in Apache Co. (NYSE:APA) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 9,729 shares of the energy company’s stock, valued at approximately $255,000.
Top 10 Value Stocks To Watch For 2022: Joby Aviation, Inc.(JOBY)
Joby Aviation, Inc. engages in the research and development of electric vertical take-off and landing aircrafts. The company was founded in 209 and is headquartered in Santa Cruz, California.
Advisors' Opinion:- [By ]
Joby Aviation (JOBY) - Get Report: "No, I don't see a lot going on there."
Meta Materials (MMATF) - Get Report: "I don't want to own it."
Top 10 Value Stocks To Watch For 2022: Coeur d'Alene Mines Corporation(CDE)
Coeur d'Alene Mines Corporation, together with its subsidiaries, engages in the ownership, operation, exploration, and development of silver and gold mining properties located primarily in South America, Mexico, the United States, and Australia. The company also explores for lead and zinc ores. Its properties include the Palmarejo mine located in the state of Chihuahua, northern Mexico; San Bartolome mine located near Potosi, Bolivia; Kensington mine located north-northwest of Juneau, Alaska; Rochester mine located in northwestern Nevada; Martha mine located in Santa Cruz, Argentina; and the Endeavor mine in New South Wales, Australia, as well as Joaquin, Tornado, and Satelite properties in Santa Cruz, Argentina. The company was founded in 1928 and is based in Coeur d?Alene, Idaho.
Advisors' Opinion:- [By Jim Robertson]
Finally, its worth mentioning that Coeur Mining, Inc (NYSE: CDE) acquired the mining concessions surrounding Pino de Plata via its acquisition of Paramount Gold and Silver Corp (NYSE: MKT; TSX: PZG) in an all-stock transaction valued at US$146 million back in 2015. In their Q4 earnings call, Company officials also stated that:
- [By Logan Wallace]
Coeur Mining Inc (NYSE:CDE) shares were down 5.5% during trading on Thursday . The stock traded as low as $4.60 and last traded at $4.62. Approximately 2,661,912 shares traded hands during trading, a decline of 12% from the average daily volume of 3,038,578 shares. The stock had previously closed at $4.89.
- [By Stephan Byrd]
Coeur Mining Inc (NYSE:CDE) SVP Hans John Rasmussen sold 7,500 shares of the company’s stock in a transaction dated Wednesday, March 6th. The stock was sold at an average price of $4.78, for a total value of $35,850.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Top 10 Value Stocks To Watch For 2022: ManpowerGroup(MAN)
ManpowerGroup Inc. is a world leader in innovative workforce solutions and services. Our global network of over 2,900 offices in 80 countries and territories allows us to meet the needs of our global, multinational and local clients across all major industry segments. We develop solutions that drive organizations forward, accelerate individual success and help build more sustainable communities. We power the world of work. By offering a comprehensive range of workforce solutions and services, we help companies at varying stages in their evolution increase productivity, improve strategy, quality and efficiency, and reduce costs across their workforce to achieve their business goals. Advisors' Opinion:
- [By Max Byerly]
Macquarie downgraded shares of ManpowerGroup (NYSE:MAN) from an outperform rating to a neutral rating in a report issued on Tuesday morning, Marketbeat Ratings reports. Macquarie currently has $91.00 target price on the business services provider’s stock.
- [By Joseph Griffin]
ManpowerGroup Inc. (NYSE:MAN) EVP Mara E. Swan sold 11,192 shares of ManpowerGroup stock in a transaction on Friday, August 31st. The shares were sold at an average price of $93.77, for a total value of $1,049,473.84. Following the completion of the sale, the executive vice president now directly owns 13,493 shares of the company’s stock, valued at approximately $1,265,238.61. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Top 10 Value Stocks To Watch For 2022: Catabasis Pharmaceuticals, Inc.(CATB)
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on our proprietary Safely Metabolized And Rationally Targeted, or SMART, linker drug discovery platform. Our SMART linker drug discovery platform enables us to engineer product candidates that can simultaneously modulate multiple targets in a disease. Our proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Our primary focus is on treatments for rare diseases. We are also developing other product candidates for the treatment of serious lipid disorders. We have applied our SMART linker drug discovery platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates. Advisors' Opinion:
- [By Max Byerly]
Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 47.6345851568851 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
- [By Shane Hupp]
Shares of Catabasis Pharmaceuticals Inc (NASDAQ:CATB) have earned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $3.54.
Top 10 Value Stocks To Watch For 2022: Boot Barn Holdings, Inc.(BOOT)
Boot Barn Holdings, Inc., a lifestyle retail company, operates specialty retail stores in the United States. The company's specialty retail stores offer western and work-related footwear, apparel, and accessories for mens, ladies, and kids. It offers boots, denim, western shirts, cowboy hats, belts and belt buckles, western-style jewelry, rugged footwear, outerwear, overalls, safety-toe boots, and flame-resistant and high-visibility clothing. As of November 3, 2015, it operated 200 stores in 29 states. The company also sells its products through bootbarn.com, an e-commerce Website. The company was formerly known as WW Top Investment Corporation and changed its name to Boot Barn Holdings, Inc. in June 2014. Boot Barn Holdings, Inc. was founded in 1978 and is headquartered in Irvine, California.
Boot Barn Holdings Inc (NYSE:BOOT)Q3 2019 Earnings Conference CallFeb. 05, 2019, 4:30 p.m. ET Operator Waddell & Reed Financial Inc. decreased its stake in shares of Boot Barn Holdings Inc (NYSE:BOOT) by 13.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 772,301 shares of the company’s stock after selling 120,322 shares during the period. Waddell & Reed Financial Inc. owned 2.76% of Boot Barn worth $16,025,000 at the end of the most recent reporting period. Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative therapeutic cell-based products in Australia, the United States, and Singapore. The company is developing therapeutic products using its proprietary technology platforms, which include mesenchymal lineage adult stem cells (MLCs) to treat conditions with unmet medical needs, including cardiac diseases, spine and musculoskeletal disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. Its lead product candidates comprise MPC-150-IM for congestive heart failures; MPC-06-ID to treat chronic lower back pain due to moderate degenerative disc diseases; MSC-100-IV for the treatment of steroid refractory acute graft versus host diseases (GVHDs); and MPC-300-IV for biologic refractory rheumatoid arthritis and diabetic nephropathy. The company is also developing JR-031 for pediatric and adult GVHDs; MPC-25-IC, which is in Phase II clinical trial to treat acute cardiac ischemia; MPC-25-Osteo that has been completed Phase II clinical trial for the treatment of spinal fusion; and MPC-CBE, which is in Phase III clinical trial to treat bone marrow transplantations. The company has strategic alliances with Lonza Group for clinical and long-term commercial production of its off-the-shelf adult stem cell products; and Teva Pharmaceutical Industries Ltd. for the development and commercialization of its MPCs for cardiovascular diseases and neurologic conditions. Mesoblast Limited was founded in 2004 and is headquartered in Melbourne, Australia. Get a free copy of the Zacks research report on Mesoblast (MESO) For more information about research offerings from Zacks Investment Research, visit Zacks.com Get a free copy of the Zacks research report on Mesoblast (MESO) For more information about research offerings from Zacks Investment Research, visit Zacks.com EQT Corporation (EQT), incorporated on June 10, 2008, is an energy company. The Company operates through two business segments: EQT Production and EQT Midstream. EQT Production is a natural gas producer in the Appalachian Basin with over 10 trillion cubic feet equivalent (Tcfe) of natural gas, natural gas liquid (NGL) and crude oil reserves across approximately 3.4 million acres, including approximately 630,000 gross acres in the Marcellus play. EQT Midstream provides gathering, transmission and storage services for the Company's produced gas and for the independent third parties across the Appalachian Basin. EQT Production Business Segment The Company's EQT Production segment conducts lateral horizontal and completion drilling in the Appalachian Basin. EQT Production's properties are located in Pennsylvania, West Virginia, Kentucky and Virginia. EQT Production encompasses all of the Company's acreage of proved developed and undeveloped natural gas and oil producing properties. The Company's proved reserves total over 10 Tcfe, consisting of proved developed producing reserves of approximately 5.8 Tcfe, proved developed non-producing reserves of approximately 0.5 Tcfe and proved undeveloped reserves of approximately 3.7 Tcfe. The Company commenced drilling operations on approximately 160 gross horizontal wells with an aggregate of approximately 868,000 feet of pay in the Marcellus, including Upper Devonian, play. The Company's wells located in Pennsylvania are primarily in Marcellus formations with depths ranging from 5,000 feet to 8,000 feet. Its wells located in West Virginia are primarily in Marcellus and Huron formations with depths ranging from 2,500 feet to 6,500 feet. Its wells located in Kentucky are primarily in Huron formations with depths ranging from 2,500 feet to 6,000 feet. Its wells located in other areas are in Coalbed Methane (CBM), Utica and Permian formations with depths ranging from 2,000 feet to 13,500 feet. EQT Production owns and leases office space in P! ennsylvania, West Virginia, Kentucky and Texas. EQT Midstream Business Segment EQT Midstream owns or operates approximately 8,250 miles of gathering lines and approximately 180 compressor units with approximately 255,000 horsepower of installed capacity, as well as other general property and equipment. The Company's EQT Midstream assets are located in the Marcellus and Utica Shales in southwestern Pennsylvania and northern West Virginia. EQT Midstream's transmission and storage system includes approximately 900 miles of Federal Energy Regulatory Commission (FERC) regulated interstate pipeline that connects to over seven interstate pipelines and multiple distribution companies. EQT Midstream's transmission and storage system is supported by approximately 20 natural gas storage reservoirs with approximately 660 million cubic feet (MMcf) per day of peak delivery capability and approximately 50 billion cubic feet (Bcf) of working gas capacity. EQT Midstream owns and leases office space in Pennsylvania, West Virginia, Virginia and Kentucky. EQT Midstream's gathering system volumes are transported to over four interstate pipelines: Columbia Gas Transmission, East Tennessee Natural Gas Company, Dominion Transmission and Tennessee Gas Pipeline Company. TRADEMARK VIOLATION NOTICE: “EQT Co. (EQT) Stake Lessened by KBC Group NV” was published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/4165438/eqt-co-eqt-stake-lessened-by-kbc-group-nv.html. Shares of EQT Co. (NYSE:EQT) traded down 5.3% during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $17.92 and last traded at $18.20. 6,704,326 shares were traded during mid-day trading, an increase of 38% from the average session volume of 4,871,953 shares. The stock had previously closed at $19.21. EQT Corp (NYSE:EQT)Q4 2018 Earnings Conference CallFeb. 14, 2019, 10:30 a.m. ET Operator However, while the entire sector looks undervalued, two sticks stand out as being insanely cheap versus their peers: EQT Corp. (NYSE:EQT) and Newfield Exploration (NYSE:NFX). Value investors will want to take a closer look at these two energy companies. Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California. ILLEGAL ACTIVITY NOTICE: “Viridium Pacific Group (VIR) Reaches New 12-Month Low at $0.47” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/4217237/viridium-pacific-group-vir-reaches-new-12-month-low-at-0-47.html. Top 10 Value Stocks To Watch For 2022: Mesoblast Limited(MESO)
Top 10 Value Stocks To Watch For 2022: EQT Corporation(EQT)
Top 10 Value Stocks To Watch For 2022: Vir Biotechnology, Inc.(VIR)
No comments:
Post a Comment